Regulus Therapeutics
RGLS
#8766
Rank
NZ$0.16 B
Marketcap
$2.46
Share price
-0.68%
Change (1 day)
9.67%
Change (1 year)

EPS for Regulus Therapeutics (RGLS)

EPS in 2023 (TTM): -$2.78

According to Regulus Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.83. In 2022 the company made an earnings per share (EPS) of -$3.11 an increase over its 2021 EPS that were of -$5.47.

EPS history for Regulus Therapeutics from 2012 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.78-10.64%
2022-$3.11-43.12%
2021-$5.47-40.55%
2020-$9.20-50%
2019-$18.40-80.36%
2018-$93.68-57.8%
2017-$221.99-28.66%
2016-$311.1642.2%
2015-$218.82-14.84%
2014-$256.96156%
2013-$100.37-98.75%
2012-$8,032

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$5.86-307.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
$5.32-288.18%๐Ÿ‡ซ๐Ÿ‡ท France
$30.88-1,192.31%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.32-217.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
-$6.88 143.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.41-14.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.64-334.91%๐Ÿ‡บ๐Ÿ‡ธ USA